Magnesium Replacement for Hypomagnesemia with Level 0.9
For severe hypomagnesemia with a magnesium level of 0.9 mg/dL, administer 2 g (16 mEq) of IV magnesium sulfate over 15-30 minutes, followed by continuous infusion of 1-2 g/hour until levels normalize. 1
Severity Assessment and Initial Management
- A serum magnesium level of 0.9 mg/dL indicates severe hypomagnesemia (<1.2 mg/dL) requiring:
Dosing Protocol
Initial Dose:
- 2 g (16 mEq) IV magnesium sulfate over 15-30 minutes 1
- Must be diluted to concentration of 20% or less prior to administration 2
- Common diluents: 5% Dextrose Injection or 0.9% Sodium Chloride Injection 2
Maintenance Dosing:
- Follow with continuous infusion of 1-2 g/hour for severe cases 1
- Alternative approach: For severe hypomagnesemia, up to 250 mg (approximately 2 mEq) per kg of body weight may be given IM within a four-hour period 2
- Another option: 5 g (approximately 40 mEq) can be added to one liter of IV fluid for slow infusion over three hours 2
Monitoring and Follow-up
- Check serum magnesium 24 hours after completion of IV therapy 1
- Continue ECG monitoring if:
- Magnesium level drops further
- Patient is on medications that prolong QT interval 1
- Target serum magnesium level of 6 mg/100 mL is considered optimal for control of seizures if present 2
- Total daily dose should not exceed 30-40 g in 24 hours 2
Special Considerations
In patients with renal impairment:
Monitor for associated electrolyte abnormalities:
Transition to Oral Therapy
- Once stabilized, transition to oral magnesium supplementation:
- Typical dosing of 12-24 mmol daily in divided doses 1
- Continue until magnesium levels normalize
Clinical Pearls and Pitfalls
- Rate of IV injection should generally not exceed 150 mg/minute 2
- Hypomagnesemia increases risk of Torsades de Pointes and ventricular arrhythmias, even with normal magnesium levels 1, 4
- Continuous use of magnesium sulfate in pregnancy beyond 5-7 days can cause fetal abnormalities 2
- Symptoms of hypomagnesemia typically don't appear until levels fall below 1.2 mg/dL 3
- Avoid magnesium in patients with WPW syndrome who are receiving calcium channel blockers or digitalis 1
By following this protocol, you can effectively correct severe hypomagnesemia while monitoring for potential complications and addressing associated electrolyte abnormalities.